435 - NATRIURETIC PEPTIDE INSIGHTS IN ACUTE MYOCARDIAL INFARCTION
JA Ezekowitz, P Theroux, WC Chang, KW Mahaffey, CB Granger, WD Weaver, JS Hochman, PW Armstrong
Edmonton, Alberta; Durham, North Carolina; Montreal, Quebec

436 - SYSTEMATIC REVIEW AND META-ANALYSIS OF BRAIN NATRIURETIC PETIDE IN THE DIAGNOSIS OF CONGESTIVE HEART FAILURE
OE Elkhateeb, I Bata
Halifax, Nova Scotia

437 - B-TYPE NATRIURETIC PEPTIDE (BNP) IN THE CLINICAL TITRATION OF BETA BLOCKER DOSAGE IN HEART FAILURE PATIENTS
LM Mielniczuk, L Beck-Da-Silva, RF Davies, A deBold, M Fraser, C Struthers, H Haddad
Ottawa, Ontario

438 - BRAIN NATRIURETIC PEPTIDE PREDICTS RIGHT VENTRICULAR SIZE AND FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
L Webster, SL Archer, ED Michelakis

439 - THE IMPACT OF SERUM DIGOXIN CONCENTRATION AND ENALAPRIL THERAPY IN PATIENTS WITH CHF: THE SOLVD TRIAL REVISITED
RJ Sheppard, S Levesque, S deDenus, A Ducharme, M Bourassa, JC Tardif, N Racine, M White
Montreal, Quebec

440 - EFFECTS OF AMLODIPINE AND ATENOLOL ON MYOCARDIAL PERFUSION ASSESSED BY PET IMAGING
K Yoshinaga, R Beanlands, R deKemp, J Morin, M Aung, T Farncombe, KY Gulenchyn, C Nahmias, R McKelvie, RF Davies
Ottawa, Ontario; Hamilton, Ontario